Experimental Evaluation of Hepatoprotective Activity in Male Albino Rats
DOI:
https://doi.org/10.64882/ijrt.v14.i3.1570Keywords:
Experimental pharmacology, Hepatoprotective activity, Liver injury, Carbon tetrachloride, Male albino rats, Oxidative stress, Antioxidant enzymes, HistopathologyAbstract
The liver is a vital organ responsible for numerous physiological processes, including metabolism, detoxification, protein synthesis, bile production, and maintenance of biochemical homeostasis. Exposure to environmental toxins, xenobiotics, alcohol, pharmaceuticals, and infectious agents can lead to hepatic injury characterized by oxidative stress, inflammation, and hepatocellular necrosis. Despite advances in pharmacotherapy, effective hepatoprotective agents with minimal adverse effects remain limited, necessitating the exploration of novel therapeutic interventions. The present study aims to experimentally evaluate the hepatoprotective potential of a test compound in male albino rats using a chemically induced hepatotoxicity model.
Healthy adult male albino rats will be randomly divided into five experimental groups: normal control, hepatotoxic control, standard treatment, and two test treatment groups receiving different doses of the investigational compound. Hepatic injury will be induced using carbon tetrachloride (CCl₄) administered intraperitoneally. The test compound will be administered orally for a predetermined treatment period. Hepatic function will be evaluated by estimating serum biochemical parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bilirubin, albumin, and total protein. Oxidative stress biomarkers, namely superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), and malondialdehyde (MDA), will be assessed in liver homogenates. Histopathological examination of liver tissues will be performed to evaluate structural alterations and tissue regeneration. Statistical analysis will be conducted using one-way analysis of variance followed by Tukey's multiple comparison test, considering p < 0.05 as statistically significant.
The study is expected to demonstrate that the investigational compound exerts hepatoprotective activity by restoring liver enzyme levels, improving antioxidant defense mechanisms, reducing lipid peroxidation, and preserving normal hepatic architecture. The findings may provide scientific evidence supporting the therapeutic potential of the test compound in the management of chemically induced liver injury and contribute to the development of safer hepatoprotective agents.
References
Asha, K., & Vidyavathi, M. (2019). Hepatoprotective activity of medicinal plants: A review. Journal of Pharmacognosy and Phytochemistry, 8(4), 1503–1512.
Czaja, A. J. (2014). Hepatic inflammation and progressive liver fibrosis. World Journal of Gastroenterology, 20(10), 2515–2532.
European Association for the Study of the Liver (EASL). (2023). Clinical practice guidelines on drug-induced liver injury. Journal of Hepatology, 79, 460–491.
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 24(7), 908–922.
Halliwell, B., & Gutteridge, J. M. C. (2015). Free radicals in biology and medicine (5th ed.). Oxford University Press.
Jaeschke, H., et al. (2021). Oxidant stress and liver injury. Antioxidants, 10(7), 1024.
Li, S., Tan, H.-Y., Wang, N., et al. (2015). The role of oxidative stress and antioxidants in liver diseases. International Journal of Molecular Sciences, 16(11), 26087–26124.
National Research Council. (2011). Guide for the care and use of laboratory animals (8th ed.). National Academies Press.
Navarro, V. J., & Senior, J. R. (2006). Drug-related hepatotoxicity. New England Journal of Medicine, 354(7), 731–739.
OECD. (2002). OECD guideline for the testing of chemicals No. 423: Acute oral toxicity—Acute toxic class method. Organisation for Economic Co-operation and Development.
OECD. (2019). Guidance document on good in vitro method practices (GIVIMP). Organisation for Economic Co-operation and Development.
Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351–358.
Percie du Sert, N., Hurst, V., Ahluwalia, A., et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biology, 18(7), e3000410.
Ramachandran, A., & Jaeschke, H. (2020). Mechanisms of acetaminophen hepatotoxicity and emerging therapies. Nature Reviews Gastroenterology & Hepatology, 17(9), 529–543.
Reitman, S., & Frankel, S. (1957). A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28(1), 56–63.
Wang, K. (2019). Molecular mechanisms of liver injury. Cell Death & Disease, 10, 1–18.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
